Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis

This publication has 24 references indexed in Scilit:

• Established breast cancer risk factors by clinically important tumour characteristics
  British Journal of Cancer, 2006
• Interactions between Body Mass Index and Hormone Therapy and Postmenopausal Breast Cancer Risk (United States)
  Cancer Causes & Control, 2006
• Relationship between Established Breast Cancer Risk Factors and Risk of Seven Different Histologic Types of Invasive Breast Cancer
  Cancer Epidemiology, Biomarkers & Prevention, 2006
• Hormone replacement therapy in relation to breast carcinoma incidence rate ratios
  Cancer, 2004
• Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe
  International Journal of Cancer, 2004
• Breast cancer and hormone-replacement therapy in the Million Women Study
  The Lancet, 2003
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy
  International Journal of Cancer, 2001
• Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
  The Lancet, 1997
• The Risk of Breast Cancer after Estrogen and Estrogen–Progestin Replacement
  New England Journal of Medicine, 1989